Recent headlines around proposed US tariffs on European countries highlight just how volatile the global trade environment remains. As reported this week  in Fierce Pharma , potential new duties on several European nations raised questions about the future of US–EU trade relations and potential impacts on pharmaceuticals. For sponsors running global clinical trials, this kind of uncertainty can translate into real operational risk: fluctuating costs, sourcing delays, and regu